Search
for
Sort by
Research 481–510 of 1000+
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Response of alopecia areata of the beard to oral tofacitinib
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Application of Baricitinib in Dermatology
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Molecular docking studies and ADME-Tox prediction of phytocompounds from Merremia peltata as a potential anti-alopecia treatment
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Immune cell regulation of the hair cycle
- Treatment-Refractory Central Centrifugal Cicatricial Alopecia Responsive to a Novel Botanical Treatment
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- JAK inhibitors in dermatology: The promise of a new drug class